Author

Kamola Saydaminova

Institution: Memorial Sloan Kettering Cancer Center

Observed institutions: Memorial Sloan Kettering Cancer Center, University of Washington

OpenAlex ID: A5012809255

Single-Molecule Nanoscopy Elucidates RNA Polymerase II Transcription at Single Genes in Live Cells

2019 · Jieru Li, Ankun Dong, et al. · Cell · 152

In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors

2016 · Maximilian Richter, Kamola Saydaminova, et al. · Blood · 99

Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation

2015 · Kamola Saydaminova, Xun Ye, et al. · Molecular Therapy — Methods & Clinical Development · 58

Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1

2015 · Hongjie Wang, Corinne Ducournau, et al. · Journal of Virology · 40

Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models

2016 · Roma Yumul, Maximilian Richter, et al. · Human Gene Therapy · 38

Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin

2015 · Maximilian Richter, Roma Yumul, et al. · Molecular Therapy — Methods & Clinical Development · 25

Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy

2017 · Charles Vragniau, Jens-Martin Hübner, et al. · Journal of Virology · 20

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic

2016 · Maximilian Richter, Roma Yumul, et al. · Molecular Therapy — Methods & Clinical Development · 16

Quantification of designer nuclease induced mutation rates: a direct comparison of different methods

2016 · Eric Ehrke-Schulz, Thorsten Bergmann, et al. · Molecular Therapy — Methods & Clinical Development · 10

Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells

2016 · Kamola Saydaminova, Robert Strauss, et al. · Cancer Biology & Therapy · 7

Preclinical safety, pharmacokinetics, pharmacodynamics and biodistribution studies with Ad35K++ protein, a novel rituximab co‐therapeutic in mice and non‐human primates.

2016 · Maximilian Richter, Roma Yumul, et al. · Edinburgh Research Explorer (University of Edinburgh)

Abstract POSTER-THER-1439: Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation and maintenance of cancer stem cells

2015 · Kamola Saydaminova, Robert Strauss, et al. · Clinical Cancer Research

123. Helper-Dependent Ad5/35 Vectors for ZFN Mediated Gene Editing in Hematopoietic Stem Cells

2015 · Kamola Saydaminova, Hongjie Wang, et al. · Molecular Therapy

458. Sensitizing Ovarian Cancer Cells To Chemotherapy By Interfering With Pathways That Are Involved in the Formation and Maintenance of Cancer Stem Cells

2015 · Kamola Saydaminova, Robert Strauss, et al. · Molecular Therapy

Works count: 14

Citation count: 465

H-index: 9

I10-index: 9